Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-203164 ◽

2013 ◽

Vol 73 (9) ◽

pp. 1665-1672 ◽

Cited By ~ 47

Author(s):

Andra Rodica Balanescu ◽

Eugen Feist ◽

Gernot Wolfram ◽

Isabelle Davignon ◽

Michael D Smith ◽

...

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793483435 ◽

2013 ◽

Author(s):

Josimari Melo DeSantana

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482796 ◽

2013 ◽

Author(s):

Carsten Bantel

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2010.04508.x ◽

2010 ◽

Vol 33 (2) ◽

pp. 213-224 ◽

Cited By ~ 22

Author(s):

Y. Kinoshita ◽

K. Ashida ◽

M. Hongo ◽

Keyword(s):

Clinical Trial ◽

Reflux Disease ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo

Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial

Asian Journal of Andrology ◽

10.1111/j.1745-7262.2008.00422.x ◽

2008 ◽

Vol 10 (5) ◽

pp. 791-798 ◽

Cited By ~ 16

Author(s):

Jae-Seung Paick ◽

Hyung-Ki Choi ◽

Sae-Chul Kim ◽

Tai-Young Ahn ◽

Je-Jong Kim ◽

...

Keyword(s):

Clinical Trial ◽

Erectile Dysfunction ◽

Fixed Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.10.009 ◽

2020 ◽

Vol 42 (12) ◽

pp. 2266-2279

Author(s):

Min-Kyung Lee ◽

Younghoon Jeon ◽

Sang Sik Choi ◽

Pyung Bok Lee ◽

Yong-Chul Kim ◽

...

Keyword(s):

Clinical Trial ◽

Neuropathic Pain ◽

Controlled Release ◽

Immediate Release ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Phase Iii Clinical Trial ◽

Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial

Epilepsy & Behavior ◽

10.1016/j.yebeh.2020.106962 ◽

2020 ◽

Vol 105 ◽

pp. 106962 ◽

Cited By ~ 3

Author(s):

Fenella Kirkham ◽

Stéphane Auvin ◽

Joana Moreira ◽

Helena Gama ◽

Amílcar C. Falcão ◽

...

Keyword(s):

Clinical Trial ◽

Adjunctive Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Multicenter Phase ◽

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)

BMC Palliative Care ◽

10.1186/s12904-019-0494-6 ◽

2019 ◽

Vol 18 (1) ◽

Cited By ~ 2

Author(s):

Phillip Good ◽

Alison Haywood ◽

Gauri Gogna ◽

Jennifer Martin ◽

Patsy Yates ◽

...

Keyword(s):

Clinical Trial ◽

Palliative Care ◽

Advanced Cancer ◽

Symptom Burden ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Relieve Symptom

Faculty Opinions recommendation of Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717953846.793459520 ◽

2012 ◽

Author(s):

Matthew DiMagno ◽

Erik Wamsteker

Keyword(s):

Clinical Trial ◽

Controlled Study ◽

Efficacy And Safety ◽

Pancreatic Exocrine Insufficiency ◽

Exocrine Insufficiency ◽

Double Blind ◽

Double Blind Placebo ◽

Pancreatic Exocrine ◽

Enteric Coated

Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study

Allergology International ◽

10.1016/j.alit.2016.05.014 ◽

2017 ◽

Vol 66 (1) ◽

pp. 97-105 ◽

Cited By ~ 9

Author(s):

Kimihiro Okubo ◽

Minoru Gotoh ◽

Mikiya Asako ◽

Yasuyuki Nomura ◽

Michinori Togawa ◽

...

Keyword(s):

Allergic Rhinitis ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Perennial Allergic Rhinitis ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Phase Iii Study